May 23, 2018

Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6

Webcast Available Through Gilead Corporate Website

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 23, 2018-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer; Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer; John McHutchison, Gilead’s Chief Scientific Officer and Head of Research & Development; and Andrew Cheng, Gilead’s Chief Medical Officer and Executive Vice President, will participate in a fireside chat at the Jefferies 2018 Healthcare Conference in New York on Wednesday, June 6 at 10:30 a.m. Eastern Time.

The audio portion of the fireside chat will be accessible live through the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

Source: Gilead Sciences, Inc.

Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor Relations

Other News

Some of the content on this page is not intended for users outside the U.S.